The data was compiled using survey that polled the general public, conducted by The Reputation Institute.
Here are the 10 companies, according to Forbes:
1. AbbVie: 74.5
2. Novo Nordisk: 74
3. Takeda Pharmaceuticals: 73.8
4. Roche: 73.4
5. Janssen Pharmaceuticals: 72.5
6. Gilead Sciences: 72.4
7. Bayer: 72.3
8. Merck Sharp & Dohme: 72.2
9. Sanofi: 72
10. Eli Lilly: 71.9
More articles on improving health:
TJR volume positively impacts hospital performance under CMS quality metrics — 3 insights
The Joint Commission awards 3 John M. Eisenberg Safety and Quality Awards
Safety culture expert: 3 things to do instead of making accreditation reports public
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
